Aberrant Subcellular Expression of Nucleophosmin and NPM-MLF1 Fusion Protein in Acute Myeloid Leukaemia Carrying T(3;5): A Comparison With NPMc+ AML

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404068
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aberrant Subcellular Expression of Nucleophosmin and NPM-MLF1 Fusion Protein in Acute Myeloid Leukaemia Carrying T(3;5): A Comparison With NPMc+ AML

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

DNA Damage Corrects the Aberrant Cytoplasmic Localisation of Nucleophosmin in NPM1 Mutated Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2019English

Acute Myeloid Leukemia Bearing Cytoplasmic Nucleophosmin (NPMc+ AML) Shows a Distinct Gene Expression Profile Characterized by Up-Regulation of Genes Involved in Stem-Cell Maintenance

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Psy68 - Costs Associated With Management of Acute Myeloid Leukaemia (Aml) Patients in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

MLL Gene Alterations in Acute Myeloid Leukaemia (11q23/Mll+ AML)

2013English

Immunophenotypic Characterisation of Morphologically Diagnosed Cases of Acute Myeloid Leukaemia (AML)

Pakistan Journal of Medical Sciences
Medicine
2019English

Identification of a Novel TFG–FGFR1 Fusion Gene in an Acute Myeloid Leukaemia Patient With T(3;8)(q12;p11)

British Journal of Haematology
Hematology
2019English

Identification of a Novel RUNX1-TACC1 Fusion Transcript in Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2020English

Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy